Price target
434.590.00 0.00%
The 9 analysts offering 1 year price forecasts for 4527/N have a max estimate of — and a min estimate of —.
Analyst rating
Based on 9 analysts giving stock ratings to 4527/N in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
4527/N EPS for the last quarter is 5.05 MXN despite the estimation of 5.01 MXN. In the next quarter EPS is expected to reach 2.32 MXN. Track more of ROHTO PHARMACEUTICAL CO financials and stay on top of what is up with the company.
In the next quarter ROHTO PHARMACEUTICAL CO revenue is expected to reach 7.81 B MXN. Check out ROHTO PHARMACEUTICAL CO revenue and earnings and make informed decisions.
According to analysts, 4527/N price target is 434.59 MXN with a max estimate of 495.24 MXN and a min estimate of 370.88 MXN. Check if this forecast comes true in a year, meanwhile watch ROHTO PHARMACEUTICAL CO stock price chart and keep track of the current situation with 4527/N news and stock market news.
We've gathered opinions of 9 analysts rating 4527/N stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.